Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06631794
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-09
Brief Title:
Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students on Their Papillomavirus Vaccination Coverage
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HPV-ADO
Brief Summary:
This is a prospective pragmatic study to assess the impact of a HPV vaccination talk in secondary school on actual vaccine dispensing in test communes compared with control communes The talk consist on a briefing on the importance of vaccination
This is a controlled study since two communes will benefit from the HPV vaccination talk while the other two will serve as controls without set up of the HPV vaccination talk The set up of this presentation will be open-label
This is a controlled study since two communes will benefit from the HPV vaccination talk while the other two will serve as controls without set up of the HPV vaccination talk The set up of this presentation will be open-label
Detailed Description:
The main aim of the present study is to investigate the impact of HPV vaccination talk with 3rd grade school children on HPV vaccine dispensing by making them actors in their own health A significant benefit on vaccination coverage is expected In addition a flyer providing information and raising awareness of infections and the benefits of HPV vaccination will be sent to parents at the end of the talk
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None